Hutch News
Dr. Meghan Koch named 2019 Rita Allen Foundation Scholar
She will study how maternal antibodies and the microbiome support growth in early life
Washington’s Andy Hill Cancer Research Endowment awards $1.5M to 3 Fred Hutch researchers
Scientists will use funds to expand research in graft-vs.-host disease, chemoprevention and cancer immunology
Data drives life sciences boom in Seattle
Hutch leaders, entrepreneurs stress importance of partnerships at Life Science Innovation Northwest conference
Could CC-Rix mice change how we think about traditional mouse models?
From the Lund Laboratory, Vaccine and Infectious Disease Division
Relatives of germinal center T cells move to the blood
From the McElrath Laboratory, Vaccine and Infectious Disease Division
Good News: Normal skin cells keep cancer at bay
Celebrating faculty and staff achievements
MAIT cells react to Malaria
From the Prlic Laboratory, Vaccine and Infectious Disease Division
With immunosequencing, what is past is prologue
From the Robins Lab, Public Health Sciences Division.
With immunotherapy trial, ‘a real paradigm shift’ in rare skin cancer
Investigators report ‘extraordinarily’ long-lasting treatment responses in patients with chemo-resistant, metastatic Merkel cell carcinoma
Immunotherapy-simplifying nanoparticle research gets boost from National Science Foundation
Celebrating faculty and staff achievements
The right tools for the job: taking immunotherapy to the next level
Dr. Matthias Stephan is combining the fields of immunology, bioengineering and gene therapy to harness the immune system to treat solid tumors
